Investigating differences between tamoxifen resistant and sensitive breast cancer cells with flow cytometry

The active metabolite of tamoxifen, 4‐hydroxytamoxifen, functions as an anti‐estrogen in breast cancer cells and thus inhibits proliferation. While tamoxifen continues to be successfully used to treat estrogen‐dependent breast cancer, most patients receiving treatment will develop chemoresistance ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitton, Aric, Zheng, Yan, Houston, Jessica P., Houston, Kevin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986838/
https://www.ncbi.nlm.nih.gov/pubmed/33508166
http://dx.doi.org/10.1002/cyto.a.24306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986838/
https://www.ncbi.nlm.nih.gov/pubmed/33508166
http://dx.doi.org/10.1002/cyto.a.24306

Ejemplares similares